Disease Information
General Information of the Disease (ID: DIS00100)
Name |
Retina cancer
|
---|---|
ICD |
ICD-11: 2D02
|
Type(s) of Resistant Mechanism of This Disease
EADR: Epigenetic Alteration of DNA, RNA or Protein
IDUE: Irregularity in Drug Uptake and Drug Efflux
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
5 drug(s) in total
Carboplatin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-mir-34 | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Carboplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). | |||
Key Molecule: hsa-miR-3163 | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Carboplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
Experiment for Molecule Alteration |
RT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Carboplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Melanoma antigen A 4 (MAGE4) | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Carboplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Cisplatin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-miR-3163 | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Cisplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
Experiment for Molecule Alteration |
RT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Cisplatin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. |
Doxorubicin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-mir-34 | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Doxorubicin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). | |||
Key Molecule: hsa-miR-3163 | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Doxorubicin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
Experiment for Molecule Alteration |
RT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Doxorubicin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Melanoma antigen A 4 (MAGE4) | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Doxorubicin | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Etoposide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-mir-34 | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Etoposide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). | |||
Key Molecule: hsa-miR-3163 | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Etoposide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
Experiment for Molecule Alteration |
RT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Etoposide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Melanoma antigen A 4 (MAGE4) | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Etoposide | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
Vincristine
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Key Molecule: hsa-mir-34 | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Vincristine | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). | |||
Key Molecule: hsa-miR-3163 | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Vincristine | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
Experiment for Molecule Alteration |
RT-PCR | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) | [2] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Down-regulation |
||
Sensitive Drug | Vincristine | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
Cell proliferation | Inhibition | hsa05200 | ||
In Vitro Model | WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 |
In Vivo Model | Nude mouse xenograft model | Mus musculus | ||
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay | |||
Mechanism Description | Silencing of ABCG2 by MicroRNA-3163 inhibits multidrug resistance in retinoblastoma cancer stem cells. | |||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Melanoma antigen A 4 (MAGE4) | [1] | |||
Sensitive Disease | Retinoblastoma [ICD-11: 2D02.2] | |||
Molecule Alteration | Expression | Up-regulation |
||
Sensitive Drug | Vincristine | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Activation | hsa04210 | |
MAGE-A/p53 signaling pathway | Regulation | hsa04115 | ||
In Vitro Model | HXO-Rb44 cells | Retina | Homo sapiens (Human) | CVCL_D542 |
SO-Rb50 cells | Retina | Homo sapiens (Human) | CVCL_D543 | |
WERI-Rb-1 cells | Retina | Homo sapiens (Human) | CVCL_1792 | |
Y79 cells | Retina | Homo sapiens (Human) | CVCL_1893 | |
Experiment for Molecule Alteration |
Western blot analysis; RT-qPCR | |||
Experiment for Drug Resistance |
Freedom Evolyzer-2200 Enzyme-Linked Immunometric meter; Flow cytometry assay | |||
Mechanism Description | miR-34a may function as a tumor suppressor for RB by targeting MAGE-A and upregulating p53 expression to enhance cell apoptosis and chemosensitivity (Carboplatin; Etoposide; Adriamycin; vincristine). |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.